NBP Stock Analysis: Buy, Sell, or Hold?
$1.32
-0.07 (-5.38%)
▼
5d:
-2.94%
30d:
-16.98%
90d:
-26.67%
WAIT
LOW Confidence
Analysis Updated: Oct 12, 2026 12:00 AM ET
Earnings: Sep 30, 2026
0d
Get Alerted When NBP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NBP shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NBP shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: NBP is currently trading at $1.32, which is considered oversold relative to its 30-day fair value range of $1.36 to $1.67.
Technical Outlook: Technically, NBP is in a downtrend. The price is currently testing key support at $1.31. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.00 (+581.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NBP is in a downtrend. The price is currently testing key support at $1.31. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.00 (+581.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.36 -
$1.67
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.4%)
- BULLISH: Trading 581.8% below Wall St target ($9.00)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.36 -
$1.67
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.31
Resistance Level
$1.44
Current Trend
Downtrend
Technical data as of
Oct 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.10
Wall Street Target
$9.00
(+581.8%)
Share & Embed Analysis
Last updated: October 12, 2026 10:45 PM ET
Data refreshes hourly during market hours. Next update: 11:45 PM
Data refreshes hourly during market hours. Next update: 11:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NBP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
27 analysts |
$92 | 62 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$109 | 70 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$285 | 52 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
17 analysts |
$37 | 64 BUY |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 73 BUY |